Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole for Anti-Doping Control
NCT04201054Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2019
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluconazole, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of fluconazole. Started Mar 2019; status: completed.
02
Drugs
fluconazole
Beyond the preview
Go deeper on NCT04201054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201054.